| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thalassemia | 57 | 2016 | 267 | 2.930 |
Why?
|
| Fetal Hemoglobin | 37 | 2016 | 346 | 1.810 |
Why?
|
| beta-Thalassemia | 8 | 2014 | 234 | 1.300 |
Why?
|
| Iron Chelating Agents | 12 | 2012 | 141 | 1.200 |
Why?
|
| Research Support as Topic | 8 | 2016 | 697 | 1.200 |
Why?
|
| National Institutes of Health (U.S.) | 8 | 2016 | 793 | 1.160 |
Why?
|
| Anemia, Sickle Cell | 25 | 2012 | 1065 | 0.810 |
Why?
|
| Biomedical Research | 8 | 2016 | 3464 | 0.730 |
Why?
|
| Hemoglobins | 24 | 2015 | 1531 | 0.730 |
Why?
|
| Hematology | 2 | 2017 | 243 | 0.720 |
Why?
|
| Iron Overload | 7 | 2012 | 245 | 0.710 |
Why?
|
| Nuclear Warfare | 1 | 2020 | 30 | 0.700 |
Why?
|
| Anemia, Aplastic | 5 | 2018 | 231 | 0.650 |
Why?
|
| Global Warming | 1 | 2020 | 79 | 0.650 |
Why?
|
| Globins | 27 | 2012 | 405 | 0.590 |
Why?
|
| Hematopoietic Stem Cells | 21 | 2018 | 3408 | 0.590 |
Why?
|
| Awards and Prizes | 3 | 2010 | 365 | 0.490 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 83 | 0.480 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 347 | 0.470 |
Why?
|
| Leucine | 10 | 2015 | 547 | 0.470 |
Why?
|
| Deferoxamine | 13 | 2003 | 155 | 0.460 |
Why?
|
| History, 20th Century | 12 | 2017 | 2765 | 0.460 |
Why?
|
| Anemia, Hemolytic, Congenital | 3 | 2014 | 71 | 0.460 |
Why?
|
| History, 21st Century | 8 | 2017 | 1574 | 0.450 |
Why?
|
| Hydrops Fetalis | 1 | 2014 | 113 | 0.440 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 136 | 0.440 |
Why?
|
| Erythropoiesis | 18 | 2011 | 691 | 0.410 |
Why?
|
| Hospital Administration | 1 | 2016 | 350 | 0.410 |
Why?
|
| Pyridones | 7 | 2003 | 819 | 0.400 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2012 | 31 | 0.390 |
Why?
|
| Interleukin-3 | 10 | 1996 | 425 | 0.390 |
Why?
|
| Virus Diseases | 1 | 2018 | 722 | 0.390 |
Why?
|
| Research Personnel | 4 | 2016 | 589 | 0.380 |
Why?
|
| Drug Industry | 3 | 2003 | 791 | 0.360 |
Why?
|
| Colony-Stimulating Factors | 8 | 1989 | 218 | 0.350 |
Why?
|
| Anemia, Diamond-Blackfan | 4 | 2018 | 147 | 0.350 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 1144 | 0.350 |
Why?
|
| Growth Substances | 7 | 1990 | 759 | 0.340 |
Why?
|
| Carrier Proteins | 2 | 2015 | 4925 | 0.340 |
Why?
|
| Hydroxyurea | 10 | 2010 | 284 | 0.340 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 1596 | 0.330 |
Why?
|
| Ion Channels | 1 | 2014 | 1043 | 0.330 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1110 | 0.310 |
Why?
|
| Natural Killer T-Cells | 1 | 2012 | 319 | 0.310 |
Why?
|
| Purines | 1 | 2012 | 614 | 0.300 |
Why?
|
| Pediatrics | 5 | 2017 | 3621 | 0.300 |
Why?
|
| Cholesterol | 1 | 2017 | 2905 | 0.300 |
Why?
|
| Research | 7 | 2002 | 1977 | 0.300 |
Why?
|
| Hemoglobinopathies | 9 | 1990 | 101 | 0.300 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 506 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1362 | 0.290 |
Why?
|
| Benzoates | 3 | 2004 | 213 | 0.290 |
Why?
|
| Hematopoiesis | 11 | 2012 | 2056 | 0.280 |
Why?
|
| Financing, Government | 2 | 2002 | 473 | 0.270 |
Why?
|
| Phosphoproteins | 1 | 2015 | 2448 | 0.260 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2061 | 0.260 |
Why?
|
| Prenatal Diagnosis | 18 | 2005 | 1271 | 0.250 |
Why?
|
| Erythrocytes | 26 | 2014 | 2411 | 0.230 |
Why?
|
| Triazoles | 3 | 2004 | 903 | 0.220 |
Why?
|
| Anemia | 7 | 2023 | 1514 | 0.220 |
Why?
|
| Education, Medical | 4 | 2004 | 1746 | 0.210 |
Why?
|
| Ethics | 1 | 2002 | 93 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3112 | 0.200 |
Why?
|
| Chelation Therapy | 5 | 2005 | 77 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
| Blood Transfusion | 13 | 2010 | 1308 | 0.200 |
Why?
|
| Bone Marrow Diseases | 4 | 2002 | 234 | 0.190 |
Why?
|
| Humans | 165 | 2023 | 767040 | 0.190 |
Why?
|
| Training Support | 1 | 2002 | 109 | 0.190 |
Why?
|
| Interinstitutional Relations | 1 | 2002 | 235 | 0.190 |
Why?
|
| Heterozygote | 13 | 2014 | 2794 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2012 | 2028 | 0.180 |
Why?
|
| Pedigree | 10 | 2016 | 4539 | 0.180 |
Why?
|
| Fanconi Anemia | 7 | 2002 | 327 | 0.180 |
Why?
|
| Genes | 11 | 1989 | 1824 | 0.180 |
Why?
|
| Societies, Medical | 3 | 2009 | 3964 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2009 | 1256 | 0.170 |
Why?
|
| Bone Marrow Transplantation | 8 | 2009 | 2710 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3610 | 0.160 |
Why?
|
| Bone Marrow Cells | 12 | 2006 | 2412 | 0.160 |
Why?
|
| Career Choice | 3 | 2002 | 769 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2055 | 0.160 |
Why?
|
| Cancer Care Facilities | 1 | 2001 | 427 | 0.150 |
Why?
|
| Physicians | 4 | 2009 | 4593 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 5794 | 0.150 |
Why?
|
| Iron | 16 | 2003 | 1811 | 0.150 |
Why?
|
| Erythropoietin | 11 | 2011 | 718 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7868 | 0.140 |
Why?
|
| Ribosomal Proteins | 3 | 2018 | 369 | 0.140 |
Why?
|
| Homozygote | 13 | 2012 | 1774 | 0.140 |
Why?
|
| Universities | 1 | 2002 | 1004 | 0.140 |
Why?
|
| Publishing | 2 | 2002 | 837 | 0.140 |
Why?
|
| Clinical Trials as Topic | 7 | 2010 | 8048 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2009 | 2341 | 0.140 |
Why?
|
| Mutation | 9 | 2018 | 30211 | 0.140 |
Why?
|
| Hemoglobin A | 6 | 1990 | 84 | 0.130 |
Why?
|
| Neoplasms | 6 | 2009 | 22350 | 0.130 |
Why?
|
| Hemoglobins, Abnormal | 10 | 1979 | 119 | 0.120 |
Why?
|
| Portraits as Topic | 1 | 2014 | 33 | 0.120 |
Why?
|
| United States | 13 | 2017 | 72971 | 0.120 |
Why?
|
| Forecasting | 3 | 2016 | 2936 | 0.120 |
Why?
|
| Osmotic Fragility | 1 | 2014 | 35 | 0.120 |
Why?
|
| Internship and Residency | 4 | 2004 | 5947 | 0.110 |
Why?
|
| Adult Children | 1 | 2014 | 104 | 0.110 |
Why?
|
| Hemoglobin E | 1 | 2012 | 6 | 0.110 |
Why?
|
| Hospitals, Pediatric | 4 | 2002 | 1856 | 0.110 |
Why?
|
| Reticulocytes | 12 | 1992 | 287 | 0.100 |
Why?
|
| Macaca fascicularis | 5 | 2005 | 908 | 0.100 |
Why?
|
| Liver Cirrhosis | 3 | 2003 | 1959 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5363 | 0.090 |
Why?
|
| Base Sequence | 16 | 2012 | 12414 | 0.090 |
Why?
|
| Heart Diseases | 3 | 2012 | 2817 | 0.090 |
Why?
|
| T-Lymphocytes | 10 | 1996 | 10254 | 0.090 |
Why?
|
| Genes, Switch | 1 | 2010 | 48 | 0.090 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 306 | 0.090 |
Why?
|
| Dihydropyridines | 1 | 1990 | 67 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 812 | 0.090 |
Why?
|
| Saudi Arabia | 6 | 1989 | 211 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 1999 | 2783 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2012 | 250 | 0.090 |
Why?
|
| Decision Making | 1 | 2004 | 3951 | 0.090 |
Why?
|
| beta-Globins | 1 | 2010 | 111 | 0.090 |
Why?
|
| Ontario | 2 | 2002 | 403 | 0.080 |
Why?
|
| Cell Count | 2 | 2012 | 1825 | 0.080 |
Why?
|
| Drug Design | 2 | 2007 | 1045 | 0.080 |
Why?
|
| Antisickling Agents | 1 | 2009 | 72 | 0.080 |
Why?
|
| Agranulocytosis | 2 | 1987 | 98 | 0.080 |
Why?
|
| Erythroid Precursor Cells | 1 | 1990 | 211 | 0.080 |
Why?
|
| Liver | 7 | 2014 | 7578 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 287 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 10748 | 0.080 |
Why?
|
| Neutropenia | 2 | 2000 | 892 | 0.080 |
Why?
|
| Phlebotomy | 1 | 2009 | 138 | 0.080 |
Why?
|
| Animals | 30 | 2016 | 168965 | 0.080 |
Why?
|
| DNA Restriction Enzymes | 6 | 1987 | 548 | 0.070 |
Why?
|
| Budgets | 2 | 2000 | 232 | 0.070 |
Why?
|
| Fetal Diseases | 3 | 2005 | 915 | 0.070 |
Why?
|
| Colony-Forming Units Assay | 6 | 1989 | 351 | 0.070 |
Why?
|
| Administration, Oral | 5 | 2005 | 4026 | 0.070 |
Why?
|
| Anemia, Hemolytic | 4 | 1981 | 164 | 0.070 |
Why?
|
| Stroke | 1 | 2009 | 9746 | 0.070 |
Why?
|
| Gene Expression Regulation | 8 | 2006 | 11923 | 0.070 |
Why?
|
| Leukemia, Lymphoid | 1 | 1987 | 307 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2014 | 1247 | 0.070 |
Why?
|
| Remission Induction | 2 | 2012 | 2408 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 2227 | 0.070 |
Why?
|
| Fetal Blood | 5 | 1989 | 1361 | 0.070 |
Why?
|
| Receptors, Erythropoietin | 2 | 1997 | 144 | 0.070 |
Why?
|
| DNA | 15 | 1993 | 7210 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 5 | 1996 | 5796 | 0.070 |
Why?
|
| Recombinant Proteins | 10 | 1997 | 6507 | 0.070 |
Why?
|
| Cell Cycle | 2 | 1985 | 2927 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2009 | 504 | 0.070 |
Why?
|
| Bone Marrow | 11 | 1986 | 2926 | 0.070 |
Why?
|
| Fetal Research | 2 | 1977 | 6 | 0.070 |
Why?
|
| Anemia, Sideroblastic | 4 | 2000 | 106 | 0.070 |
Why?
|
| Morbidity | 1 | 2011 | 1754 | 0.070 |
Why?
|
| Hematopoietic Cell Growth Factors | 3 | 1992 | 98 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 7 | 1996 | 892 | 0.060 |
Why?
|
| Human Experimentation | 2 | 1977 | 125 | 0.060 |
Why?
|
| Male | 42 | 2018 | 364203 | 0.060 |
Why?
|
| Intestinal Absorption | 2 | 2003 | 400 | 0.060 |
Why?
|
| Macaca mulatta | 4 | 1992 | 2345 | 0.060 |
Why?
|
| Aging | 1 | 2023 | 8729 | 0.060 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2005 | 158 | 0.060 |
Why?
|
| Models, Animal | 1 | 2010 | 2121 | 0.060 |
Why?
|
| Fetus | 6 | 1985 | 1878 | 0.060 |
Why?
|
| Ribosomes | 5 | 2018 | 497 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2012 | 1304 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 960 | 0.060 |
Why?
|
| Erythrocytes, Abnormal | 3 | 1981 | 121 | 0.060 |
Why?
|
| Adolescent | 20 | 2018 | 89046 | 0.060 |
Why?
|
| Macaca | 2 | 1982 | 413 | 0.060 |
Why?
|
| Cell Separation | 2 | 1986 | 1717 | 0.050 |
Why?
|
| Thiazoles | 1 | 1990 | 1530 | 0.050 |
Why?
|
| Case Management | 1 | 2005 | 277 | 0.050 |
Why?
|
| Erythroblasts | 3 | 1989 | 141 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2017 | 5914 | 0.050 |
Why?
|
| Cells, Cultured | 12 | 2006 | 18989 | 0.050 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2005 | 184 | 0.050 |
Why?
|
| Ferritins | 3 | 2003 | 601 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2005 | 5716 | 0.050 |
Why?
|
| Freedom | 1 | 2002 | 69 | 0.050 |
Why?
|
| Child, Preschool | 17 | 2018 | 42606 | 0.050 |
Why?
|
| Cell Death | 1 | 2007 | 1677 | 0.050 |
Why?
|
| Adult | 36 | 2014 | 223317 | 0.050 |
Why?
|
| Hematocrit | 8 | 1992 | 622 | 0.050 |
Why?
|
| Erythrocyte Count | 7 | 1984 | 157 | 0.050 |
Why?
|
| Pregnancy | 22 | 2005 | 30238 | 0.050 |
Why?
|
| Anemia, Hypochromic | 6 | 1983 | 62 | 0.050 |
Why?
|
| Boston | 5 | 2005 | 9360 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2003 | 1639 | 0.050 |
Why?
|
| Female | 53 | 2018 | 396660 | 0.050 |
Why?
|
| Splenectomy | 6 | 1990 | 390 | 0.050 |
Why?
|
| RNA, Messenger | 10 | 2004 | 12793 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2140 | 0.050 |
Why?
|
| Infant, Newborn | 13 | 2005 | 26396 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2002 | 735 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 15851 | 0.050 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 616 | 0.050 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2003 | 553 | 0.040 |
Why?
|
| Foundations | 1 | 2000 | 95 | 0.040 |
Why?
|
| Swimming | 1 | 1981 | 212 | 0.040 |
Why?
|
| Cell Survival | 3 | 2007 | 5750 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8736 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1804 | 0.040 |
Why?
|
| Child | 23 | 2018 | 80771 | 0.040 |
Why?
|
| Dyskeratosis Congenita | 1 | 2000 | 70 | 0.040 |
Why?
|
| Career Mobility | 1 | 2002 | 262 | 0.040 |
Why?
|
| Gene Expression | 4 | 1996 | 7587 | 0.040 |
Why?
|
| Lymphocyte Activation | 4 | 1993 | 5499 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2010 | 2979 | 0.040 |
Why?
|
| Hemoglobin H | 1 | 1979 | 13 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1983 | 527 | 0.040 |
Why?
|
| Disease | 1 | 2005 | 675 | 0.040 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 17608 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2002 | 435 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 451 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2002 | 2605 | 0.040 |
Why?
|
| Moloney murine leukemia virus | 1 | 1999 | 110 | 0.040 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1999 | 93 | 0.040 |
Why?
|
| Hemolysis | 5 | 2010 | 417 | 0.040 |
Why?
|
| Monocytes | 3 | 1989 | 2598 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 1604 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 21526 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2001 | 417 | 0.040 |
Why?
|
| Cell Division | 5 | 1999 | 4473 | 0.040 |
Why?
|
| Hemosiderosis | 3 | 1990 | 66 | 0.040 |
Why?
|
| Physical Exertion | 1 | 1981 | 667 | 0.040 |
Why?
|
| Carbon Isotopes | 10 | 1972 | 453 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2627 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2000 | 354 | 0.040 |
Why?
|
| Confidentiality | 1 | 2002 | 607 | 0.040 |
Why?
|
| Chromatography | 6 | 1980 | 189 | 0.040 |
Why?
|
| Phagocytosis | 5 | 1990 | 1526 | 0.040 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 29 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 1981 | 1384 | 0.040 |
Why?
|
| Europe | 1 | 2005 | 3432 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2002 | 556 | 0.040 |
Why?
|
| Hemoglobinometry | 5 | 1972 | 35 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 1998 | 162 | 0.040 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 2 | 1976 | 147 | 0.040 |
Why?
|
| Hemoglobinuria, Paroxysmal | 2 | 2010 | 96 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 5 | 1987 | 113 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2001 | 554 | 0.030 |
Why?
|
| Glyceric Acids | 2 | 1973 | 17 | 0.030 |
Why?
|
| Canada | 1 | 2002 | 2127 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1998 | 384 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 1977 | 685 | 0.030 |
Why?
|
| Bloodletting | 3 | 1992 | 22 | 0.030 |
Why?
|
| Blood Protein Electrophoresis | 5 | 1980 | 65 | 0.030 |
Why?
|
| Social Control, Formal | 1 | 1977 | 107 | 0.030 |
Why?
|
| Capsid | 1 | 1999 | 435 | 0.030 |
Why?
|
| Syndrome | 2 | 2000 | 3271 | 0.030 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2744 | 0.030 |
Why?
|
| Gestational Age | 8 | 2003 | 3618 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11513 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 115 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2002 | 2658 | 0.030 |
Why?
|
| Physicians, Women | 2 | 1993 | 516 | 0.030 |
Why?
|
| Bone Marrow Examination | 4 | 1975 | 154 | 0.030 |
Why?
|
| Time Factors | 8 | 2012 | 40154 | 0.030 |
Why?
|
| Siderosis | 1 | 1977 | 100 | 0.030 |
Why?
|
| Social Change | 1 | 1977 | 152 | 0.030 |
Why?
|
| Hydrogen Peroxide | 4 | 1972 | 740 | 0.030 |
Why?
|
| Haplotypes | 4 | 2004 | 2722 | 0.030 |
Why?
|
| Endonucleases | 1 | 1978 | 371 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2003 | 1512 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 243 | 0.030 |
Why?
|
| Models, Biological | 2 | 2010 | 9464 | 0.030 |
Why?
|
| Granulocytes | 3 | 1988 | 551 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 640 | 0.030 |
Why?
|
| Uremia | 2 | 1968 | 202 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 1979 | 1776 | 0.030 |
Why?
|
| Middle Aged | 13 | 2014 | 223233 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2002 | 5022 | 0.030 |
Why?
|
| Infant | 11 | 2005 | 36485 | 0.030 |
Why?
|
| Policy Making | 1 | 1998 | 546 | 0.030 |
Why?
|
| Mice | 7 | 2010 | 81912 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 1965 | 0.030 |
Why?
|
| Exons | 2 | 2018 | 2391 | 0.030 |
Why?
|
| Chromosome Mapping | 4 | 1989 | 4616 | 0.030 |
Why?
|
| Blood Proteins | 2 | 1969 | 1190 | 0.030 |
Why?
|
| Cyanates | 1 | 1973 | 22 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2001 | 1090 | 0.030 |
Why?
|
| DNA Mutational Analysis | 3 | 2012 | 4114 | 0.030 |
Why?
|
| Erythrocyte Aging | 3 | 1981 | 52 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1207 | 0.030 |
Why?
|
| Granuloma | 3 | 1971 | 329 | 0.030 |
Why?
|
| Vinblastine | 2 | 1985 | 482 | 0.030 |
Why?
|
| Hexokinase | 2 | 1971 | 124 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3402 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 2003 | 1263 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 16036 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1990 | 1617 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2002 | 1135 | 0.030 |
Why?
|
| Azacitidine | 2 | 1985 | 336 | 0.030 |
Why?
|
| Cell Communication | 1 | 1980 | 1660 | 0.030 |
Why?
|
| Glycolysis | 3 | 1971 | 836 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 1973 | 209 | 0.030 |
Why?
|
| Government Regulation | 1 | 1977 | 525 | 0.020 |
Why?
|
| Phenotype | 6 | 2018 | 16718 | 0.020 |
Why?
|
| Lymphadenitis | 2 | 1971 | 99 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2002 | 3591 | 0.020 |
Why?
|
| Amniotic Fluid | 4 | 1979 | 381 | 0.020 |
Why?
|
| Transfection | 3 | 2002 | 5753 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1979 | 3621 | 0.020 |
Why?
|
| Fetoscopy | 3 | 1979 | 140 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2001 | 1300 | 0.020 |
Why?
|
| Butyrates | 1 | 1992 | 164 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1990 | 3642 | 0.020 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 1971 | 26 | 0.020 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1972 | 62 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 1646 | 0.020 |
Why?
|
| Interleukin-2 | 3 | 1990 | 1894 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1655 | 0.020 |
Why?
|
| Hydro-Lyases | 1 | 1971 | 93 | 0.020 |
Why?
|
| Methylation | 2 | 1984 | 1076 | 0.020 |
Why?
|
| Cell Fractionation | 2 | 1987 | 245 | 0.020 |
Why?
|
| Adenosine Triphosphate | 3 | 1972 | 2001 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2007 | 23621 | 0.020 |
Why?
|
| Androgens | 2 | 1972 | 1281 | 0.020 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1971 | 149 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2018 | 2668 | 0.020 |
Why?
|
| Fluorides | 1 | 1971 | 134 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 1992 | 145 | 0.020 |
Why?
|
| Genetic Counseling | 2 | 1990 | 635 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1984 | 1606 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1990 | 1801 | 0.020 |
Why?
|
| Glucose | 3 | 1972 | 4341 | 0.020 |
Why?
|
| Priapism | 1 | 2010 | 28 | 0.020 |
Why?
|
| Tritium | 4 | 1974 | 707 | 0.020 |
Why?
|
| Killer Cells, Natural | 3 | 1990 | 2209 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2004 | 1989 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2011 | 300 | 0.020 |
Why?
|
| Leukocytes | 4 | 1971 | 2034 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1975 | 606 | 0.020 |
Why?
|
| Leg Ulcer | 1 | 2010 | 71 | 0.020 |
Why?
|
| Hemochromatosis | 2 | 1982 | 175 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1990 | 175 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 3 | 2003 | 917 | 0.020 |
Why?
|
| Testosterone | 4 | 2003 | 2490 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1990 | 266 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1983 | 3114 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1990 | 228 | 0.020 |
Why?
|
| Transcription, Genetic | 4 | 1989 | 7611 | 0.020 |
Why?
|
| Iron Isotopes | 2 | 1968 | 19 | 0.020 |
Why?
|
| Phagocytes | 1 | 1990 | 292 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2010 | 411 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12451 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2012 | 22254 | 0.020 |
Why?
|
| Potassium | 2 | 1972 | 1314 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3702 | 0.020 |
Why?
|
| Binding Sites | 3 | 1996 | 6014 | 0.020 |
Why?
|
| Biopsy | 2 | 1998 | 6777 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 1987 | 4838 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3738 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1989 | 373 | 0.020 |
Why?
|
| Reference Values | 2 | 2006 | 4918 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 959 | 0.020 |
Why?
|
| Blood Platelets | 3 | 1987 | 2464 | 0.020 |
Why?
|
| Culture Media | 2 | 1989 | 892 | 0.020 |
Why?
|
| Risk | 4 | 1985 | 9606 | 0.020 |
Why?
|
| Glutathione | 2 | 1971 | 589 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 13650 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1992 | 1156 | 0.020 |
Why?
|
| Students, Medical | 1 | 2000 | 1965 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2012 | 65295 | 0.020 |
Why?
|
| Drug Synergism | 2 | 1989 | 1759 | 0.020 |
Why?
|
| Fatty Acids | 2 | 1972 | 1806 | 0.020 |
Why?
|
| Zygote | 1 | 1987 | 117 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1990 | 1352 | 0.020 |
Why?
|
| Cell Line | 4 | 1997 | 15567 | 0.020 |
Why?
|
| Neutrophils | 2 | 1987 | 3779 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 3449 | 0.020 |
Why?
|
| Faculty, Medical | 2 | 1992 | 1227 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1969 | 409 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1990 | 1305 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1981 | 326 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 898 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2010 | 361 | 0.020 |
Why?
|
| Legislation as Topic | 2 | 1977 | 76 | 0.020 |
Why?
|
| Giant Cell Tumors | 1 | 1986 | 89 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1987 | 766 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1970 | 1688 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 861 | 0.020 |
Why?
|
| Multigene Family | 1 | 1989 | 1081 | 0.020 |
Why?
|
| Injections, Intramuscular | 2 | 1977 | 551 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 6106 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 2006 | 2342 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 1282 | 0.020 |
Why?
|
| Placenta | 6 | 1977 | 1726 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1988 | 631 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1733 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 2 | 1974 | 113 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1964 | 189 | 0.010 |
Why?
|
| Pyelonephritis | 1 | 1964 | 76 | 0.010 |
Why?
|
| Minority Groups | 1 | 1992 | 1214 | 0.010 |
Why?
|
| Polyribosomes | 2 | 1974 | 109 | 0.010 |
Why?
|
| Interphase | 1 | 1985 | 226 | 0.010 |
Why?
|
| Physiology | 1 | 1964 | 112 | 0.010 |
Why?
|
| Haplorhini | 1 | 1985 | 520 | 0.010 |
Why?
|
| Protein Biosynthesis | 3 | 1976 | 2093 | 0.010 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1983 | 14 | 0.010 |
Why?
|
| Blood | 4 | 1977 | 596 | 0.010 |
Why?
|
| Pharmacology | 1 | 1963 | 97 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2010 | 1003 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1968 | 928 | 0.010 |
Why?
|
| Pyruvate Kinase | 1 | 1985 | 191 | 0.010 |
Why?
|
| Heme | 2 | 1964 | 316 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1964 | 509 | 0.010 |
Why?
|
| Data Collection | 1 | 1992 | 3321 | 0.010 |
Why?
|
| Pyruvates | 2 | 1973 | 84 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 1964 | 333 | 0.010 |
Why?
|
| Anemia, Megaloblastic | 1 | 1962 | 24 | 0.010 |
Why?
|
| Cell Differentiation | 4 | 1996 | 11657 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 655 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1990 | 3154 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 137 | 0.010 |
Why?
|
| Chromosome Breakage | 1 | 2002 | 159 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1987 | 976 | 0.010 |
Why?
|
| Demography | 1 | 1987 | 1641 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2002 | 148 | 0.010 |
Why?
|
| Methionine | 2 | 1974 | 570 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1996 | 1550 | 0.010 |
Why?
|
| Mitomycin | 1 | 2002 | 261 | 0.010 |
Why?
|
| Protein Binding | 2 | 1996 | 9327 | 0.010 |
Why?
|
| Desiccation | 1 | 1981 | 77 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1103 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1985 | 537 | 0.010 |
Why?
|
| Liver Extracts | 1 | 1961 | 6 | 0.010 |
Why?
|
| Probability | 1 | 1986 | 2476 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1983 | 897 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 861 | 0.010 |
Why?
|
| Chromium Isotopes | 3 | 1971 | 28 | 0.010 |
Why?
|
| Kidney | 2 | 1968 | 7063 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 792 | 0.010 |
Why?
|
| Drug Administration Schedule | 3 | 1985 | 4855 | 0.010 |
Why?
|
| Calcium | 2 | 1990 | 5792 | 0.010 |
Why?
|
| Species Specificity | 1 | 1985 | 2412 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1961 | 108 | 0.010 |
Why?
|
| Lod Score | 1 | 2001 | 600 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2002 | 437 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1964 | 1987 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1993 | 2420 | 0.010 |
Why?
|
| Heart Failure | 1 | 2005 | 11877 | 0.010 |
Why?
|
| RNA | 1 | 1990 | 2715 | 0.010 |
Why?
|
| Rheology | 1 | 1981 | 346 | 0.010 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 1980 | 15 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1990 | 2697 | 0.010 |
Why?
|
| Mitosis | 1 | 1985 | 1176 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 350 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 846 | 0.010 |
Why?
|
| Ascorbic Acid | 3 | 1977 | 658 | 0.010 |
Why?
|
| Abortion, Induced | 2 | 1977 | 471 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1980 | 116 | 0.010 |
Why?
|
| Contrast Sensitivity | 1 | 2001 | 253 | 0.010 |
Why?
|
| Infusions, Parenteral | 2 | 1977 | 395 | 0.010 |
Why?
|
| Erythroid Cells | 1 | 1961 | 237 | 0.010 |
Why?
|
| Vitamin B 6 | 1 | 1961 | 237 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1996 | 9612 | 0.010 |
Why?
|
| Aged | 5 | 2011 | 171319 | 0.010 |
Why?
|
| Sickle Cell Trait | 2 | 1976 | 86 | 0.010 |
Why?
|
| Peptide Fragments | 4 | 1976 | 5141 | 0.010 |
Why?
|
| Methods | 3 | 1974 | 1065 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1980 | 404 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1990 | 697 | 0.010 |
Why?
|
| Electrophoresis, Starch Gel | 2 | 1975 | 19 | 0.010 |
Why?
|
| Abortion, Eugenic | 2 | 1978 | 39 | 0.010 |
Why?
|
| Freezing | 1 | 1980 | 310 | 0.010 |
Why?
|
| Geriatrics | 1 | 1963 | 394 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1979 | 455 | 0.010 |
Why?
|
| Radiography | 2 | 1985 | 6975 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1981 | 1729 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8535 | 0.010 |
Why?
|
| Blood Volume | 1 | 1980 | 543 | 0.010 |
Why?
|
| Cell Membrane Permeability | 2 | 1972 | 568 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1975 | 292 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 4424 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1983 | 1334 | 0.010 |
Why?
|
| Ammonia | 1 | 1958 | 244 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1987 | 2387 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1985 | 1349 | 0.010 |
Why?
|
| Graft vs Host Disease | 2 | 1987 | 3049 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1982 | 2275 | 0.010 |
Why?
|
| Diphosphoglyceric Acids | 2 | 1975 | 31 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1974 | 297 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1989 | 5891 | 0.010 |
Why?
|
| Asia | 1 | 1979 | 629 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2002 | 842 | 0.010 |
Why?
|
| Aborted Fetus | 1 | 1977 | 11 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4572 | 0.010 |
Why?
|
| NAD | 2 | 1971 | 618 | 0.010 |
Why?
|
| Transcription Factors | 2 | 1996 | 12158 | 0.010 |
Why?
|
| Kinetics | 1 | 1985 | 6287 | 0.010 |
Why?
|
| Peptide Chain Elongation, Translational | 2 | 1974 | 31 | 0.010 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 1961 | 386 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1979 | 2168 | 0.010 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1976 | 45 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1976 | 186 | 0.010 |
Why?
|
| Genotype | 3 | 1979 | 13035 | 0.010 |
Why?
|
| Thymidine | 1 | 1996 | 297 | 0.010 |
Why?
|
| Sodium | 2 | 1972 | 1594 | 0.010 |
Why?
|
| TATA Box | 1 | 1996 | 127 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1981 | 1673 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1979 | 498 | 0.010 |
Why?
|
| Leukemia | 2 | 1996 | 1518 | 0.010 |
Why?
|
| Hormones | 1 | 1980 | 865 | 0.010 |
Why?
|
| Carbon Radioisotopes | 2 | 1974 | 544 | 0.010 |
Why?
|
| Phospholipids | 2 | 1971 | 778 | 0.010 |
Why?
|
| Estradiol | 1 | 2003 | 1951 | 0.010 |
Why?
|
| Chemistry | 1 | 1976 | 327 | 0.010 |
Why?
|
| Government | 1 | 1977 | 161 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41718 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1996 | 458 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1976 | 486 | 0.010 |
Why?
|
| Electrophoresis, Paper | 1 | 1974 | 14 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1981 | 2677 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2628 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 59980 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1057 | 0.010 |
Why?
|
| Biopsy, Needle | 2 | 1977 | 1615 | 0.010 |
Why?
|
| Legislation, Medical | 1 | 1975 | 99 | 0.010 |
Why?
|
| Birth Weight | 1 | 2003 | 2122 | 0.010 |
Why?
|
| Federal Government | 1 | 1977 | 266 | 0.010 |
Why?
|
| Fetal Death | 1 | 1976 | 434 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1974 | 199 | 0.010 |
Why?
|
| Immunoglobulin Fragments | 1 | 1975 | 83 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 705 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 2602 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1996 | 321 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1996 | 1081 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 1985 | 4247 | 0.010 |
Why?
|
| Stem Cells | 1 | 1987 | 3535 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 1837 | 0.010 |
Why?
|
| Luciferases | 1 | 1996 | 713 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1992 | 1377 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1976 | 1623 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 18330 | 0.010 |
Why?
|
| Extraembryonic Membranes | 1 | 1974 | 37 | 0.010 |
Why?
|
| Trypsin | 1 | 1974 | 490 | 0.010 |
Why?
|
| Trisomy | 1 | 1975 | 260 | 0.010 |
Why?
|
| Body Composition | 1 | 1963 | 2454 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 2626 | 0.010 |
Why?
|
| State Government | 1 | 1977 | 388 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 1976 | 284 | 0.010 |
Why?
|
| Sulfites | 1 | 1973 | 83 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1993 | 17 | 0.010 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 1993 | 30 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1974 | 100 | 0.010 |
Why?
|
| Host Cell Factor C1 | 1 | 1993 | 35 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1985 | 4560 | 0.010 |
Why?
|
| Umbilical Cord | 2 | 1974 | 179 | 0.010 |
Why?
|
| Inosine | 1 | 1973 | 129 | 0.010 |
Why?
|
| Fluoxymesterone | 1 | 1972 | 12 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1992 | 51 | 0.010 |
Why?
|
| Viscosity | 1 | 1973 | 334 | 0.010 |
Why?
|
| Public Opinion | 1 | 1977 | 484 | 0.010 |
Why?
|
| Methyltestosterone | 1 | 1972 | 19 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1976 | 853 | 0.010 |
Why?
|
| Sodium Isotopes | 1 | 1972 | 11 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1972 | 9 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1972 | 52 | 0.010 |
Why?
|
| Phosphoric Acids | 1 | 1972 | 19 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 1974 | 238 | 0.010 |
Why?
|
| Glycine | 2 | 1967 | 670 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 1973 | 213 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1972 | 66 | 0.010 |
Why?
|
| Oxygen | 2 | 1975 | 4252 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1980 | 12986 | 0.010 |
Why?
|
| Bilirubin | 2 | 1971 | 440 | 0.010 |
Why?
|
| Vitamin E Deficiency | 1 | 1972 | 30 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1980 | 1172 | 0.010 |
Why?
|
| Ouabain | 1 | 1972 | 246 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 1958 | 1029 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1972 | 323 | 0.010 |
Why?
|
| Age Factors | 2 | 1981 | 18401 | 0.010 |
Why?
|
| Phosphofructokinase-1 | 1 | 1971 | 50 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1975 | 737 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1972 | 384 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1972 | 130 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1972 | 339 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1971 | 79 | 0.010 |
Why?
|
| Fatty Acids, Essential | 1 | 1972 | 97 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2001 | 2714 | 0.010 |
Why?
|
| Lactates | 1 | 1972 | 398 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 1966 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1971 | 94 | 0.010 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1990 | 16 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1971 | 291 | 0.010 |
Why?
|
| Genetics, Medical | 2 | 1964 | 334 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1971 | 128 | 0.010 |
Why?
|
| Autoradiography | 1 | 1972 | 725 | 0.010 |
Why?
|
| Methylene Blue | 1 | 1971 | 156 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 9660 | 0.010 |
Why?
|
| Needles | 1 | 1974 | 461 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1970 | 61 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1971 | 529 | 0.010 |
Why?
|
| Cyanides | 1 | 1971 | 82 | 0.010 |
Why?
|
| Agar | 1 | 1970 | 51 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 2391 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1971 | 612 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 2659 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 1996 | 12536 | 0.010 |
Why?
|
| Acrylates | 1 | 1970 | 75 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2003 | 2057 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1971 | 209 | 0.010 |
Why?
|
| Starch | 1 | 1970 | 81 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 26325 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1972 | 405 | 0.010 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1970 | 83 | 0.010 |
Why?
|
| Informed Consent | 1 | 1977 | 1010 | 0.010 |
Why?
|
| Staff Development | 1 | 1992 | 231 | 0.010 |
Why?
|
| Politics | 1 | 1977 | 822 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 1969 | 92 | 0.010 |
Why?
|
| Phosphates | 1 | 1973 | 765 | 0.010 |
Why?
|
| Pregnant Women | 1 | 1975 | 576 | 0.010 |
Why?
|
| Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 1971 | 56 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1971 | 1309 | 0.010 |
Why?
|
| Copper | 1 | 1972 | 365 | 0.010 |
Why?
|
| Zymosan | 1 | 1969 | 134 | 0.010 |
Why?
|
| Superoxides | 1 | 1990 | 388 | 0.010 |
Why?
|
| Peroxidases | 1 | 1969 | 134 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1976 | 1278 | 0.010 |
Why?
|
| Gels | 1 | 1970 | 421 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1982 | 2330 | 0.000 |
Why?
|
| Electrodes | 1 | 1971 | 612 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1531 | 0.000 |
Why?
|
| Peptides | 1 | 1981 | 4348 | 0.000 |
Why?
|
| Nursing Staff, Hospital | 1 | 1992 | 350 | 0.000 |
Why?
|
| Accreditation | 1 | 1992 | 477 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6421 | 0.000 |
Why?
|
| Palmitic Acids | 1 | 1968 | 53 | 0.000 |
Why?
|
| Logistic Models | 1 | 2003 | 13284 | 0.000 |
Why?
|
| Risk Management | 1 | 1992 | 558 | 0.000 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1989 | 186 | 0.000 |
Why?
|
| Israel | 1 | 1990 | 726 | 0.000 |
Why?
|
| Oxygen Consumption | 2 | 1971 | 1873 | 0.000 |
Why?
|
| Oxidation-Reduction | 2 | 1971 | 2221 | 0.000 |
Why?
|
| Graft Survival | 1 | 1999 | 3896 | 0.000 |
Why?
|
| Hylobates | 1 | 1987 | 13 | 0.000 |
Why?
|
| Lymphatic Diseases | 1 | 1969 | 318 | 0.000 |
Why?
|
| Medical Staff, Hospital | 1 | 1992 | 602 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 305 | 0.000 |
Why?
|
| Drug Therapy, Combination | 2 | 1992 | 6310 | 0.000 |
Why?
|
| Rabbits | 1 | 1974 | 4751 | 0.000 |
Why?
|
| Skull | 1 | 1972 | 819 | 0.000 |
Why?
|
| Carbon Monoxide | 1 | 1971 | 559 | 0.000 |
Why?
|
| X Chromosome | 1 | 1990 | 819 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1980 | 4210 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1971 | 840 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1996 | 1883 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1987 | 11872 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1968 | 393 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1969 | 861 | 0.000 |
Why?
|
| Reimbursement Mechanisms | 1 | 1992 | 670 | 0.000 |
Why?
|
| Procarbazine | 1 | 1985 | 172 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1982 | 4357 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1996 | 4167 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1996 | 8310 | 0.000 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1985 | 99 | 0.000 |
Why?
|
| Acute Disease | 1 | 1976 | 7236 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2003 | 13048 | 0.000 |
Why?
|
| Primary Myelofibrosis | 2 | 1977 | 208 | 0.000 |
Why?
|
| Centrifugation | 1 | 1965 | 121 | 0.000 |
Why?
|
| Busulfan | 1 | 1985 | 259 | 0.000 |
Why?
|
| Hemoglobin A2 | 1 | 1964 | 6 | 0.000 |
Why?
|
| Continuity of Patient Care | 1 | 1992 | 1078 | 0.000 |
Why?
|
| Epoetin Alfa | 1 | 1964 | 78 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20169 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1980 | 3626 | 0.000 |
Why?
|
| Prognosis | 2 | 1996 | 29963 | 0.000 |
Why?
|
| Teaching | 1 | 1992 | 1172 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1969 | 587 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1985 | 490 | 0.000 |
Why?
|
| Diet | 1 | 1982 | 8089 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 10092 | 0.000 |
Why?
|
| Transferrin | 1 | 1964 | 283 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1972 | 2163 | 0.000 |
Why?
|
| Massachusetts | 1 | 1975 | 8890 | 0.000 |
Why?
|
| Glucose Oxidase | 2 | 1971 | 18 | 0.000 |
Why?
|
| Pathology | 1 | 1964 | 270 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1976 | 2478 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1974 | 6000 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1985 | 1264 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1985 | 2227 | 0.000 |
Why?
|
| Siblings | 1 | 1964 | 828 | 0.000 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1964 | 372 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1992 | 3618 | 0.000 |
Why?
|
| Methylprednisolone | 1 | 1980 | 386 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1992 | 5537 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1968 | 1790 | 0.000 |
Why?
|
| Cytarabine | 1 | 1980 | 695 | 0.000 |
Why?
|
| Vincristine | 1 | 1980 | 1040 | 0.000 |
Why?
|
| Chronic Disease | 2 | 1970 | 9362 | 0.000 |
Why?
|
| Metabolic Diseases | 1 | 1964 | 684 | 0.000 |
Why?
|
| Greece | 1 | 1978 | 340 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1992 | 4306 | 0.000 |
Why?
|
| England | 1 | 1978 | 533 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1975 | 148 | 0.000 |
Why?
|
| Risk Assessment | 1 | 1977 | 24299 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1975 | 277 | 0.000 |
Why?
|
| Hemagglutination | 1 | 1974 | 32 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39317 | 0.000 |
Why?
|
| Biological Transport | 1 | 1958 | 2084 | 0.000 |
Why?
|
| Polycythemia | 1 | 1975 | 124 | 0.000 |
Why?
|
| Methotrexate | 1 | 1980 | 1718 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1980 | 2229 | 0.000 |
Why?
|
| Immune Sera | 1 | 1974 | 605 | 0.000 |
Why?
|
| New York | 1 | 1975 | 879 | 0.000 |
Why?
|
| Heinz Bodies | 1 | 1971 | 5 | 0.000 |
Why?
|
| Methemoglobin | 1 | 1971 | 25 | 0.000 |
Why?
|
| Brain | 1 | 1958 | 27163 | 0.000 |
Why?
|
| Transaminases | 1 | 1971 | 198 | 0.000 |
Why?
|
| Latex | 1 | 1970 | 49 | 0.000 |
Why?
|
| Proteins | 1 | 1965 | 6001 | 0.000 |
Why?
|
| Risk Factors | 1 | 1996 | 74886 | 0.000 |
Why?
|
| Amino Acids | 1 | 1975 | 1712 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1976 | 81659 | 0.000 |
Why?
|
| Microspheres | 1 | 1970 | 774 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1968 | 676 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1980 | 7469 | 0.000 |
Why?
|